Physician profile
David M Pfeffer
NPI 1124108600
$674.02
in general payments reported to CMS, 2019-2025
12 companies · $25.98 in 2025
The $25.98 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $163 · 2022: $47.88 · 2023: $61.21 · 2024: $181 · 2025: $25.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $150.92 | 2019-2023 | Erleada |
| Avanos Medical | $143.57 | 2024 | On-Q* Pump and Accessories |
| Terumo Medical Corporation | $131.92 | 2020 | |
| Pfizer INC. | $60.48 | 2019-2020 | |
| Blue Earth Diagnostics | $47.23 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $28.44 | 2023 | Orgovyx |
| Henry Schein, INC. | $25.98 | 2025 | |
| Janssen Pharmaceuticals, INC | $23.20 | 2019 | |
| Myriad Genetic Laboratories, INC. | $21.39 | 2022 | |
| Tolmar, INC. | $16.44 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.26 | 2019 | |
| Astellas Pharma US INC | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pfeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.